Literature DB >> 15459139

Sarcoidosis: social predictors of severity at presentation.

D L Rabin1, B Thompson, K M Brown, M A Judson, X Huang, D T Lackland, G L Knatterud, H Yeager, C Rose, J Steimel.   

Abstract

To determine relationships among social predictors and sarcoidosis severity at presentation, demographic characteristics, socioeconomic status, and barriers to care, A Case-Control Etiologic Study of Sarcoidosis (ACCESS) was set up. Patients self-reported themselves to be Black or White and were tissue-confirmed incident cases aged > or =l8-yrs-old (n=696) who had received uniform assessment procedures within one of 10 medical centres and were studied using standardised questionnaires and physical, radiographical, and pulmonary function tests. Severity was measured by objective disease indicators, subjective measures of dyspnoea and short form-36 subindices. The results of the study showed that lower income, the absence of private or Medicare health insurance, and other barriers to care were associated with sarcoidosis severity at presentation, as were race, sex, and age. Blacks were more likely to have severe disease by objective measures, while women were more likely than males to report subjective measures of severity. Older individuals were more likely to have severe disease by both measures. In conclusion, it was found that low income and other financial barriers to care are significantly associated with sarcoidosis severity at presentation even after adjusting for demographic characteristics of race, sex, and age.

Entities:  

Mesh:

Year:  2004        PMID: 15459139     DOI: 10.1183/09031936.04.00070503

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Quality of life in sarcoidosis: comparing the impact of ocular and non-ocular involvement of the disease.

Authors:  Leorey N Saligan; Grace Levy-Clarke; Tongtong Wu; Lisa J Faia; Keith Wroblewski; Steven Yeh; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

2.  Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Authors:  Bryan S Benn; Zoe Lehman; Sharon A Kidd; Melissa Ho; Sara Sun; Joris Ramstein; Nicholas K Arger; Christine P Nguyen; Robert Su; Antonio Gomez; Jeffrey M Gelfand; Laura L Koth
Journal:  Lung       Date:  2017-07-13       Impact factor: 2.584

Review 3.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

4.  Hospitalization Among Patients with Sarcoidosis: A Population-Based Cohort Study 1987-2015.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Sara J Achenbach; Eva M Carmona; Eric L Matteson
Journal:  Lung       Date:  2017-04-29       Impact factor: 2.584

5.  Sarcoidosis manifesting as a pseudotumorous renal mass.

Authors:  Scott Goldsmith; Matt Harris; Kurt Scherer; Samer Al-Quran; Elizabeth Vorhis
Journal:  J Radiol Case Rep       Date:  2013-05-01

6.  Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis.

Authors:  Logan J Harper; Alicia K Gerke; Xiao-Feng Wang; Manuel L Ribeiro Neto; Robert P Baughman; Kelli Beyer; Marjolein Drent; Marc A Judson; Lisa A Maier; Leslie Serchuck; Noopur Singh; Daniel A Culver
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

7.  Barriers to Care among Patients with Sarcoidosis: A Qualitative Study.

Authors:  Logan J Harper; Gabrielle Love; Rijuta Singh; Andre Smith; Daniel A Culver; J Daryl Thornton
Journal:  Ann Am Thorac Soc       Date:  2021-11

Review 8.  Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.

Authors:  Nisha A Gilotra; Jan M Griffin; Noelle Pavlovic; Brian A Houston; Jessica Chasler; Colleen Goetz; Jonathan Chrispin; Michelle Sharp; Edward K Kasper; Edward S Chen; Ron Blankstein; Leslie T Cooper; Emer Joyce; Farooq H Sheikh
Journal:  J Card Fail       Date:  2021-07-11       Impact factor: 5.712

9.  Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study.

Authors:  Alicia K Gerke; Ming Yang; Fan Tang; Joseph E Cavanaugh; Philip M Polgreen
Journal:  BMC Pulm Med       Date:  2012-07-09       Impact factor: 3.317

10.  Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.

Authors:  Nicolas Belhomme; Stéphane Jouneau; Guillaume Bouzillé; Olivier Decaux; Mathieu Lederlin; Stéphanie Guillot; Antoinette Perlat; Patrick Jégo
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.